March 5, 2021
Why are lung cancer deaths in non-smokers on the rise?
Why are lung cancer deaths in non-smokers on the rise? The proportion of non-smoker lung cancer patients jumped from 8% in 1990 to 15% in 2013.
Times Colonist
Research News
Explore our curated selection of the latest breakthroughs in lung cancer research.
March 5, 2021
Why are lung cancer deaths in non-smokers on the rise? The proportion of non-smoker lung cancer patients jumped from 8% in 1990 to 15% in 2013.
Times Colonist
March 2, 2021
Merck pulls Keytruda for SCLC. Pharmaceutical company, Merck announced plans to pull Ketruda for SCLC due to disappointing results from Phase III trial.
Biospace
February 19, 2021
Antibody hinders EGFR lung cancer: Johnson&Johnson’s drug shows succes in hindering tumor growth in 74% of lung cancer patients with EGFR mutations.
FIERCEBiotech
February 11, 2021
Study defines SCLC subtypes. Study provides a transformative new system to define four major groups of small-cell lung cancer.
Mirage
February 11, 2021
How biomarkers impact treatment decisions. Biomarkers indicate that a patient’s immune system knows that the tumor is there.
CURE Magazine
February 10, 2021
Genetics influence SCLC risk: The genetic factors that influence small cell lung cancer risk have not received a great deal of attention from scientists.
National Cancer Institute
February 10, 2021
Exploring saliva in early lung cancer detection: UCLA School of Dentistry researchers are looking at saliva for its diagnostic possibilities.
Medical Device and Diagnostic Industry
February 2, 2021
A sizable body of research has long shown racial disparities in treatment and survival between Black and White patients with lung cancer.
Pulmonology Advisor
January 26, 2021
Lung cancer stigma negatively impacts the clinical care and outcomes of those diagnosed, resulting in enduring disparities.
The Journal of Thoracic Oncology
January 26, 2021
Lung cancer in never smokers is becoming more prominent – especially in women. 12% of U.S. lung cancer patients are never-smokers and it is increasing.
STAT
January 25, 2021
January 14, 2021
FDA approves new liquid biopsy tests using NGS to detect tumor DNA, aiding targeted cancer therapy selection.
LabTestsOnline
Learn more about:
LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers.